The present study reveals a previously undescribed oncogenic mechanism by which p38-mediated EZH2 phosphorylation at T367 promotes breast cancer progression by inducing EZH2 cytoplasmic function and reducing nuclear EZH2 methyltransferase activity on histone H3K27. Here, EZH2 is linked to breast cancer.